ADS Diagnostics (BOM:523031) Debt-to-Equity : 0.35 (As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is ADS Diagnostics Debt-to-Equity?

ADS Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹18.1 Mil. ADS Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹2.7 Mil. ADS Diagnostics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹60.1 Mil. ADS Diagnostics's debt to equity for the quarter that ended in Mar. 2024 was 0.35.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for ADS Diagnostics's Debt-to-Equity or its related term are showing as below:

BOM:523031' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.35 Med: 1.23 Max: 2.17
Current: 0.35

During the past 13 years, the highest Debt-to-Equity Ratio of ADS Diagnostics was 2.17. The lowest was 0.35. And the median was 1.23.

BOM:523031's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.215 vs BOM:523031: 0.35

ADS Diagnostics Debt-to-Equity Historical Data

The historical data trend for ADS Diagnostics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADS Diagnostics Debt-to-Equity Chart

ADS Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

1.66

1.45

0.97

0.58

0.35

ADS Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.58	0.57	N/A	0.35

Competitive Comparison of ADS Diagnostics's Debt-to-Equity

For the Medical Devices subindustry, ADS Diagnostics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ADS Diagnostics's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ADS Diagnostics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where ADS Diagnostics's Debt-to-Equity falls into.

ADS Diagnostics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

ADS Diagnostics's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.104	+	2.737)	/	60.142
	=	0.35

ADS Diagnostics's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.104	+	2.737)	/	60.142
	=	0.35

ADS Diagnostics (BOM:523031) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

ADS Diagnostics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of ADS Diagnostics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ADS Diagnostics (BOM:523031) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ADS Diagnostics Ltd (BOM:523031) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

114, Sant Nagar, East of Kailash, New Delhi, IND, 110065

Website

https://www.adsdiagnosticlimited.com

ADS Diagnostics Ltd is an India based company engaged in the sale of medical equipment. It is focused on the business activity of the sale of trading goods, servicing and installation of medical equipment, lease rental, and distribution. The company generates key revenue from the sale of trading goods. It sells its products and services in India and internationally.

ADS Diagnostics (BOM:523031) Headlines

No Headlines